Company Data
Outlook Therapeutics Inc.
Ticker
OTLK
Current Price
$0.4385 4.01%
Market Cap
$36.4M
Price Target
Refer to Report
Volume
782.3K
52wk Range
$0.3801 - $3.39
Overview
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.